295
* Member of the American Academy of Microbiology and ** Full Professor of Infectious Diseases, Catholic University, Rome
In an article recently published by Salute we have dealt with the issue of recalls with Covid-19 mRNA vaccines. These vaccines, in the current two-dose administration form, have shown high efficacy and a more than acceptable safety profile, even in the presence of a recognized systemic reactogenicity, in particular after the second dose.
.